Odyssey Health Income Statement

Financials in millions USD. Fiscal year is August - July.

Millions USD. Fiscal year is Aug - Jul.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 31, 2026	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022
Selling, General & Admin	0.91	1.02	2.08	2.12	2.92
Research & Development	-	-	0.06	0.2	1.32
Operating Expenses	0.91	1.02	2.14	5.14	8.11
Operating Income	-0.91	-1.02	-2.14	-5.14	-8.11
Interest Expense	-1.58	-0.25	-0.52	-0.61	-0.84
Other Non Operating Income (Expenses)	-3.99	-0.01	0.01	0.01	0.5
EBT Excluding Unusual Items	-6.49	-1.28	-2.65	-5.75	-8.44
Gain (Loss) on Sale of Investments	-	-0.46	-14.59	-	-
Gain (Loss) on Sale of Assets	-	-	16.4	-	-
Other Unusual Items	0.76	-	-	-	-
Pretax Income	-5.73	-1.74	-0.84	-5.92	-8.44
Net Income	-5.73	-1.74	-0.84	-5.92	-8.44
Preferred Dividends & Other Adjustments	-	-	0.06	-	-
Net Income to Common	-5.73	-1.74	-0.91	-5.92	-8.44
Net Income Growth	-	-	-	-	-
Shares Outstanding (Basic)	108	105	97	83	89
Shares Outstanding (Diluted)	108	105	97	83	89
Shares Change	3.45%	7.88%	17.40%	-7.10%	-5.06%
EPS (Basic)	-0.05	-0.02	-0.01	-0.07	-0.09
EPS (Diluted)	-0.05	-0.02	-0.01	-0.07	-0.09
EPS Growth	-	-	-	-	-

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jul '26 Jul 31, 2026	Jul '25 Jul 31, 2025	Jul '24 Jul 31, 2024	Jul '23 Jul 31, 2023	Jul '22 Jul 31, 2022
Free Cash Flow	-1.05	-0.35	-1.22	-1.47	-3.18
Free Cash Flow Per Share	-0.01	-0.00	-0.01	-0.02	-0.04
EBITDA	-	-1.02	-2.14	-5.14	-8.1
D&A For EBITDA	-	0	0	0	0
EBIT	-0.91	-1.02	-2.14	-5.14	-8.11